Johnson TM, Molina KC, Howard AH, Schwarz K, et al. Real-World Comparison of Bezlotoxumab to Standard of Care Therapy for Prevention of Recurrent Clostridioides difficile Infection in Patients at High Risk for Recurrence. Clin Infect Dis 2022;74:1572-1578.
PMID: 34665248